BIOMAT Database Logo BIOMAT Database Logo

[Long-term therapeutic efficacy of captopril in the treatment of essential and secondary hypertension]. 1984

N Glorioso, and P Madeddu, and P Dessì Fulgheri, and M Oppes, and G C Tonolo, and F Bandiera, and G Manca, and A Rappelli

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D006978 Hypertension, Renovascular Hypertension due to RENAL ARTERY OBSTRUCTION or compression. Hypertension, Goldblatt,Goldblatt Syndrome,Goldblatt Hypertension,Renovascular Hypertension,Syndrome, Goldblatt
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011392 Proline A non-essential amino acid that is synthesized from GLUTAMIC ACID. It is an essential component of COLLAGEN and is important for proper functioning of joints and tendons. L-Proline,L Proline
D002216 Captopril A potent and specific inhibitor of PEPTIDYL-DIPEPTIDASE A. It blocks the conversion of ANGIOTENSIN I to ANGIOTENSIN II, a vasoconstrictor and important regulator of arterial blood pressure. Captopril acts to suppress the RENIN-ANGIOTENSIN SYSTEM and inhibits pressure responses to exogenous angiotensin. (S)-1-(3-Mercapto-2-methyl-1-oxopropyl)-L-proline,Capoten,Lopirin,SQ-14,225,SQ-14,534,SQ-14225,SQ-14534,SQ 14,225,SQ 14,534,SQ 14225,SQ 14534,SQ14,225,SQ14,534,SQ14225,SQ14534
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006929 Hyperaldosteronism A condition caused by the overproduction of ALDOSTERONE. It is characterized by sodium retention and potassium excretion with resultant HYPERTENSION and HYPOKALEMIA. Aldosteronism,Conn Syndrome,Conn's Syndrome,Primary Hyperaldosteronism,Conns Syndrome,Hyperaldosteronism, Primary,Syndrome, Conn,Syndrome, Conn's
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor

Related Publications

N Glorioso, and P Madeddu, and P Dessì Fulgheri, and M Oppes, and G C Tonolo, and F Bandiera, and G Manca, and A Rappelli
Long-term efficacy of captopril in renovascular and essential hypertension.
April 1982, The American journal of cardiology,
N Glorioso, and P Madeddu, and P Dessì Fulgheri, and M Oppes, and G C Tonolo, and F Bandiera, and G Manca, and A Rappelli
[Efficacy of captopril in the long-term treatment of essential hypertension of moderate-medium degree].
November 1985, La Clinica terapeutica,
N Glorioso, and P Madeddu, and P Dessì Fulgheri, and M Oppes, and G C Tonolo, and F Bandiera, and G Manca, and A Rappelli
Long-term experience of captopril in the treatment of primary (essential) hypertension.
January 1982, British journal of clinical pharmacology,
N Glorioso, and P Madeddu, and P Dessì Fulgheri, and M Oppes, and G C Tonolo, and F Bandiera, and G Manca, and A Rappelli
Long-term effects of captopril and atenolol in essential hypertension.
January 1985, Acta medica Scandinavica,
N Glorioso, and P Madeddu, and P Dessì Fulgheri, and M Oppes, and G C Tonolo, and F Bandiera, and G Manca, and A Rappelli
Haemodynamic and clinical effects of long-term treatment of essential hypertension with captopril.
July 1983, European heart journal,
N Glorioso, and P Madeddu, and P Dessì Fulgheri, and M Oppes, and G C Tonolo, and F Bandiera, and G Manca, and A Rappelli
Captopril in the long-term treatment of essential hypertension: changes in the renin-angiotensin-aldosterone system.
April 1982, The American journal of cardiology,
N Glorioso, and P Madeddu, and P Dessì Fulgheri, and M Oppes, and G C Tonolo, and F Bandiera, and G Manca, and A Rappelli
Long-term efficacy of angiotensin-converting-enzyme inhibition with captopril in mild-to-moderate essential hypertension.
January 1982, British journal of clinical pharmacology,
N Glorioso, and P Madeddu, and P Dessì Fulgheri, and M Oppes, and G C Tonolo, and F Bandiera, and G Manca, and A Rappelli
Long-term treatment of childhood hypertension with captopril.
July 1982, Pediatric annals,
N Glorioso, and P Madeddu, and P Dessì Fulgheri, and M Oppes, and G C Tonolo, and F Bandiera, and G Manca, and A Rappelli
[Long-term efficacy and tolerability of captopril in the therapy of arterial hypertension].
July 1986, La Clinica terapeutica,
N Glorioso, and P Madeddu, and P Dessì Fulgheri, and M Oppes, and G C Tonolo, and F Bandiera, and G Manca, and A Rappelli
[Treatment of essential arterial hypertension in the elderly with low-dose captopril and hydrochlorothiazide. Long-term study].
September 1987, Revista clinica espanola,
Copied contents to your clipboard!